제33호-7차

Similar documents
@12호-end2

제5호-9차

15호-출력

제3호-최종


°Ç°�°úÁúº´6-2È£

°Ç°�°úÁúº´5-44È£ÃÖÁ¾


제7호 6차

제17호

제9호

768 PUBLIC HEALTH WEEKLY REPORT, KCDC 있으며, 국제적 정보 공유 및 국내 수행 임상시험과 임상연구의 우수성을 홍보할 수 있는 기회를 마련할 수 있을 것이다. II. 몸 말 임상연구정보서비스시스템(CRIS)에는 임상연구의 종류 (중재연구,

°Ç°�°úÁúº´6-24È£

°Ç°�°úÁúº´6-13È£ÀÛ¾÷

7권30호-웹.indd

주간건강과질병 제 9 권제 11 호 국민건강영양조사구강검사질관리소개 질병관리본부질병예방센터건강영양조사과이혜린, 오경원 * * 교신저자 : / Abstract Quality control of oral health ex

Àü¿°º´ °¨½Ã¿¬º¸.PDF

도쿄도 감염증 주보

ISSN: X PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.10 No CONTENTS 0442 국내생물안전 3 등급연구시설설치 운영및안전관리현황 년의료기관종사자대상결핵역학조사결

한국성인에서초기황반변성질환과 연관된위험요인연구


건강과질병-6권27호.indd

pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.12, No. 10, 2019 CONTENTS 년예방접종이상반응신고및피해보상현황분석 0274 통계단신

Vol.8 No ISSN: X PUBLIC HEALTH WEEKLY REPORT, PHWR CONTENTS 0870 신변종바이러스확인진단에서세포배양의중요성과의의 년감염병감시체계운영결과 0886 해외여

pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.11 No CONTENTS 년국내엔테로바이러스실험실표본감시결과 0188 식이보충제복용및영

K O R E A C E N T E R S F O R D I S E A S E C O N T R O L & P R E V E N T I O N PHWR Vol. 5 No 년 2 월 24 일제 5 권 / 제 8 호 / IS

주간건강과질병 제 12 권제 1 호 연구단신, Brief report 앙코르와트여행자에서발생한유비저감염사례 질병관리본부감염병관리센터감염병감시과이신영, 이지연, 조은희 * * 교신저자 : A case with melioi

예방접종관리과

1..

012임수진

기획7.hwp

Vol.266 C O N T E N T S M O N T H L Y P U B L I C F I N A N C E F O R U M

부속

서론 34 2


건강과질병-6권28호-color.indd

주간건강과질병 제 11 권제 1 호 연구논문, Research article 216 년국내급성설사질환원인바이러스실험실감시현황 질병관리본부감염병분석센터바이러스분석과조승례, 이덕용, 강춘 * * 교신저자 : Result

주간건강과질병 제 11 권제 15 호 연구논문, Research article 미세먼지의건강영향과건강보호수칙 질병관리본부기획조정부미래감염병대비과조현정, 박성우, 이희일, 이상원 * * 교신저자 : Health effec

한국 출산력의 저하 요인에 관한 연구

pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.11, No CONTENTS 년국내일본뇌염실험실검사현황 0949 감염병실험실검

2010도통계표지도큐

저작자표시 - 비영리 - 변경금지 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비영리. 귀하는이저작물을영리목적으로이용할

Special Issue

ISSN: X PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.10 No CONTENTS 년성매개감염진료지침개정 0212 국내 C 형간염의현황과대책 0220 주요통계환자감시 / 전수

pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.11, No.42, 2018 CONTENTS 년만 1-3 세어린이정기예방접종의완전접종률현황 1417

< C7D8BEE7BCF6BBEAC5EBB0E8BFACBAB82E687770>


pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.11, No CONTENTS 0564 국내에서분리된비브리오패혈증균의유전학적다양성 0570 국내소아천식의클

pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.11 No CONTENTS 년국내메르스의심환자감시및대응결과 0128 탄저균 poly-γ-

DIABETES FACT SHEET IN KOREA 2012 SUMMARY About 3.2 million Korean people (10.1%) aged over 30 years or older had diabetes in Based on fasting g


Main Title

부산교육 311호

歯1.PDF

pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.11 No CONTENTS 0488 차세대염기서열분석법을이용한 A 형인플루엔자바이러스전장유전자생산 049

년 12 월 27 일제 6 권 / 제 52 호 / ISSN: X 피코르나바이러스의병원성결정에관여하는요인들 Virulence determining factors of Picornavirus 질질병관리본부국립보건연구원감염


pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.12, No. 20, 2019 CONTENTS 년온열질환응급실감시체계운영결과 0639 일개노인요양시설

전립선암발생률추정과관련요인분석 : The Korean Cancer Prevention Study-II (KCPS-II)


SARS 유입 및 전파 방지 대책

주간건강과질병 제 8 권제 40 호 우리나라청소년손상입원환자의역학적특성 년퇴원손상환자조사결과를중심으로 - Characteristics of Injured Inpatients among Adolescents in Korea: the Results of Kor

00약제부봄호c03逞풚

pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.10 No CONTENTS 년공수병예방을위한국내동물교상환자감시현황 년

,,,.,,,, (, 2013).,.,, (,, 2011). (, 2007;, 2008), (, 2005;,, 2007).,, (,, 2010;, 2010), (2012),,,.. (, 2011:,, 2012). (2007) 26%., (,,, 2011;, 2006;

untitled

Lumbar spine

2 제 8 권제 1 호 있는질환이다. 국내비만유병률에대한국민건강영양조사의결과보고서에따르면최근 3년간남녀각각 36% 및 26% 수준으로유지되고있으며, 이러한비만은단순한개인의신체적문제뿐아니라당뇨, 고혈압, 관상동맥등주요만성복합질환의위험요인이기때문에더욱위험한질환이라볼수있다.


pissn X eissn PUBLIC HEALTH WEEKLY REPORT, PHWR Vol.12, No. 28, 2019 CONTENTS 년국내분리백일해균주의유전형및독소유전자분석 09

【표 1

03권동희(17-26)ok

약수터2호최종2-웹용


∞«∞≠∞˙¡˙∫¥_4-5»£-3¬˜

김범수

DBPIA-NURIMEDIA


Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: * The

<30322EC6AFC1FD30342DC1A4B9AEC7F62E687770>

년 10 월 18 일제 6 권 / 제 42 호 / ISSN: X 라임병의심환자에대한분자면역학적실험실진단및특성분석 ( ) Sero-immuno diagnosis and characterization ana

YI Ggodme : The Lives and Diseases of Females during the Latter Half of the Joseon Dynasty as Reconstructed with Cases in Yeoksi Manpil (Stray Notes w

< FB4EBB1B8BDC320BAB8B0C7BAB9C1F6C5EBB0E8BFACBAB820B9DFB0A320BFACB1B85FBEF6B1E2BAB92E687770>

39 PUBLIC HEALTH WEEKLY REPORT, KCDC 2000년사이에 1,368건이발생보고되었고, 모든군의약 1/6(543/3143) 에서발생보고되었다. Martha's Vineyard 섬은미국내에서최초폐렴형야토병이 2번이나반복으로발병한지역으로알려져있고,

<B1B9C1A6B0B3B9DFC7F9B7C25FC3B9B0C9C0BD5FB3BBC1F62E706466>

주간건강과질병 제 11 권제 31 호 연구논문, Research article 결핵백신효능평가를위한바이오마커개발현황 질병관리본부국립보건연구원감염병연구센터백신연구과이영란, 정혜숙, 신은경, 윤진승, 유정식, 정경태 * * 교신저자 : 4

264 축되어 있으나, 과거의 경우 결측치가 있거나 폐기물 발생 량 집계방법이 용적기준에서 중량기준으로 변경되어 자료 를 활용하는데 제한이 있었다. 또한 1995년부터 쓰레기 종 량제가 도입되어 생활폐기물 발생량이 이를 기점으로 크 게 줄어들었다. 그러므로 1996년부

CZECH REPUBLIC SLOVAK REPUBLIC ANGOLA ARMENIA AZERBAIJAN BAHRAIN BOTSWANA BULGARIA CROATIA CYPRUS DENMARK ESTONIA FINLAND GEORGIA GREECE HUNGARY ICELA

(Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern (Micro- Environment) Re

CZECH REPUBLIC SLOVAK REPUBLIC ANGOLA ARMENIA AZERBAIJAN BAHRAIN BOTSWANA BULGARIA CROATIA CYPRUS DENMARK ESTONIA FINLAND GEORGIA GREECE HUNGARY ICELA

서론

DBPIA-NURIMEDIA

[<1107><1169><11AB><1106><116E><11AB>] 2015<1102><1167><11AB> 7<110B><116F><11AF><1112><1169>-<110E><116C><110C><1169><11BC>.pdf

hwp

590호(01-11)

212년 하반기 금리전망 및 채권투자전략 그림 1 주요국 국채1년 금리 추이 (%) Spain Italy Korea Malaysia China Australia US UK Germany Japan 자료:

16(2)-7(p ).fm

, Analyst, , Table of contents 2

. 45 1,258 ( 601, 657; 1,111, 147). Cronbach α=.67.95, 95.1%, Kappa.95.,,,,,,.,...,.,,,,.,,,,,.. :,, ( )

2월1일자.hwp

Transcription:

www.cdc.go.kr/phwr Measuring health related quality of life using EQ-5D in South Korea - Based on the results of KNHANES and -1-541 546 549 550 Public Health Weekly Report, KCDC 541

Table 1. General characteristics of study participants in KNHANES and unit : N(%) KNHANES KNHANES Male Female Male Female All 11,392 (46.1) 13,308 (53.9) 1,240 (41.6) 1,741 (58.4) Age group 19-29 1,971 (17.3) 2,438 (18.3) 141 (11.4) 198 (11.4) 30-39 2,605 (22.9) 2,815 (21.2) 247 (19.9) 388 (22.3) 40-49 2,736 (24.0) 2,974 (22.3) 248 (20.0) 317 (18.2) 50-59 1,880 (16.5) 2,005 (15.1) 205 (16.5) 300 (17.2) 60-69 1,420 (12.5) 1,722 (12.9) 216 (17.4) 273 (15.7) 70-79 618 ( 5.4) 1,034 ( 7.8) 161 (13.0) 211 (12.1) 80-162 ( 1.4) 320 ( 2.4) 22 ( 1.8) 54 ( 3.1) Residence Dong 9,133 (80.2) 10,694 (80.4) 867 (69.9) 1251 (71.9) Eup or Myeon 2,259 (19.8) 2,614 (19.6) 373 (30.1) 490 (28.1) Education Elementary or less 1,745 (15.7) 3,829 (29.5) 290 (23.4) 652 (37.6) Middle school 1,211 (10.9) 1,437 (11.1) 145 (11.7) 177 (10.2) High school 4,679 (42.2) 4,840 (37.2) 431 (34.8) 547 (31.5) University or more 3,465 (31.2) 2,893 (22.3) 371 (30.0) 360 (20.7) Occupation Non-manual 4,298 (37.7) 3,798 (28.5) 409 (33.0) 401 (23.0) Manual 4,253 (37.3) 2,271 (17.1) 421 (34.0) 277 (15.9) Others 2,841 (24.9) 7,239 (54.4) 410 (33.1) 1,063 (61.1) Subjective health Very good 651 ( 5.7) 447 ( 3.4) 66 ( 5.3) 40 ( 2.3) Good 5,089 (44.7) 4,753 (36.7) 367 (29.6) 447 (25.7) Moderate 3,793 (33.3) 4,859 (36.5) 585 (47.3) 814 (46.8) Bad 1,584 (13.9) 2,829 (21.3) 192 (15.5) 354 (20.3) Very bad 274 ( 2.4) 420 ( 3.2) 28 ( 2.3) 85 ( 4.9) The data without education or subjective health information were excluded for the analysis related to these variables. 542 Public Health Weekly Report, KCDC

Table 2. Crude problems reported(%) in EQ-5D and EQ VAS by general characteristics in KNHANES, 2005 Mobility Self-care Usual activities Pain/discomfort Anxiety/depression EQ VAS 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 Mean (SD) Median (IQR) All population 88.2 11.2 0.6 97.2 2.2 0.5 90.3 8.9 0.8 68.2 29.6 2.2 80.8 17.7 1.5 72.0 (16.9) 75.0 (20.0) Sex Male 91.9 7.5 0.6 97.6 1.9 0.6 92.5 6.7 0.9 74.8 23.4 1.8 86.1 12.6 1.2 74.1 (16.2) 80.0 (15.0) Female 85.0 14.4 0.6 97.0 2.6 0.5 88.4 10.9 0.7 62.5 34.9 2.5 76.3 22.0 1.7 70.2 (17.3) 70.0 (20.0) Age 19-29 98.7 1.3 0.0 99.7 0.3 0.0 98.6 1.3 0.1 87.4 12.3 0.3 90.1 9.6 0.3 77.9 (14.3) 80.0 (20.0) 30-39 98.6 1.3 0.1 99.7 0.2 0.1 98.0 1.8 0.2 82.1 17.7 0.3 87.8 11.7 0.5 75.5 (14.4) 80.0 (15.0) 40-49 95.7 4.2 0.1 99.0 1.0 0.1 95.6 4.1 0.2 74.2 24.7 1.1 82.6 16.3 1.1 73.6 (15.8) 80.0 (20.0) 50-59 86.7 12.9 0.4 97.6 1.9 0.5 89.4 10.0 0.5 60.9 36.4 2.6 77.1 20.9 2.0 70.2 (17.3) 70.0 (20.0) 60-69 69.7 29.1 1.2 94.4 4.6 1.0 78.1 20.5 1.4 41.9 53.1 5.0 69.4 27.3 3.2 65.1 (18.2) 70.0 (30.0) 70-79 54.1 43.5 2.4 88.4 9.5 2.1 63.5 33.1 3.4 30.6 61.0 8.4 63.4 32.9 3.7 61.0 (18.5) 60.0 (25.0) 80-36.7 56.2 7.1 72.6 20.5 6.8 42.1 49.0 8.9 24.7 64.7 10.6 61.4 33.6 5.0 57.9 (18.8) 60.0 (20.0) Education Elementary or less 63.5 34.8 1.7 91.4 7.1 1.5 71.8 26.5 2.2 37.4 56.3 6.3 66.0 30.3 3.7 63.2 (18.7) 60.0 (30.0) Middle school 87.2 12.2 0.5 97.6 1.9 0.6 89.1 10.0 0.9 60.6 36.8 2.6 76.3 22.1 1.5 69.4 (17.1) 70.0 (20.0) High school 96.4 3.4 0.2 99.1 0.7 0.2 96.4 3.4 0.2 77.8 21.4 0.8 85.1 13.9 0.9 74.8 (15.2) 80.0 (15.0) University or more 98.2 1.7 0.1 99.4 0.4 0.1 98.2 1.6 0.2 83.7 15.9 0.4 89.5 10.3 0.3 76.8 (14.3) 80.0 (20.0) Occupation Non-manual 97.1 2.9 0.0 99.6 0.3 0.0 97.6 2.3 0.0 81.3 18.0 0.7 87.6 12.0 0.4 74.3 (14.5) 75.0 (16.0) Manual 88.5 11.4 0.1 98.7 1.1 0.1 90.9 9.0 0.1 63.7 34.7 1.6 81.9 17.1 1.0 71.4 (16.5) 70.0 (20.0) Others 80.9 17.8 1.3 94.4 4.5 1.2 84.0 14.2 1.8 60.6 35.6 3.8 74.7 22.6 2.7 69.5 (18.1) 70.0 (20.0) Subjective Very good 99.0 1.0 0.0 99.8 0.2 0.0 99.2 0.8 0.0 92.1 7.7 0.3 93.5 6.3 0.2 85.9 (12.8) 90.0 (15.0) health Good 97.9 2.1 0.0 99.6 0.3 0.1 98.3 1.6 0.1 86.9 12.9 0.2 91.3 8.5 0.3 80.1 (12.2) 80.0 (20.0) Moderate 92.6 7.3 0.1 99.0 1.0 0.1 94.5 5.4 0.1 68.4 30.9 0.7 82.6 16.8 0.6 70.5 (14.0) 70.0 (20.0) Bad 64.2 34.8 1.0 93.1 6.0 0.9 70.9 27.8 1.2 29.2 65.4 5.4 58.1 38.3 3.6 57.9 (16.3) 60.0 (20.0) Very bad 30.8 56.8 12.4 64.6 25.1 10.4 34.0 49.6 16.4 10.7 57.9 31.4 34.6 47.0 18.4 44.0 (19.7) 45.0 (24.0) Table 3. Crude problems reported(%) in EQ-5D and EQ VAS by general characteristics in KNHANES -1, 2007 Mobility Self-care Usual activities Pain/discomfort Anxiety/depression EQ VAS 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 Mean (SD) Median (IQR) All population 78.1 21.2 0.7 94.2 5.2 0.6 84.1 14.7 1.2 64.9 30.4 4.7 80.2 18.1 1.7 70.5 (18.1) 70.0 (20.0) Sex Male 83.7 15.6 0.6 95.4 3.7 0.9 87.8 10.9 1.3 74.0 23.6 2.4 87.9 11.0 1.1 72.6 (16.2) 75.0 (20.0) Female 74.1 25.1 0.8 93.3 6.3 0.4 81.4 17.4 1.1 58.5 35.2 6.3 74.7 23.1 2.1 69.0 (19.2) 70.0 (28.0) Age 19-29 96.8 3.2 0.0 99.4 0.6 0.0 97.3 2.7 0.0 84.4 15.0 0.6 87.3 12.1 0.6 74.0 (14.9) 75.0 (17.0) 30-39 96.5 3.3 0.2 99.4 0.5 0.1 97.3 2.5 0.2 78.6 20.8 0.6 87.1 12.9 0.0 73.6 (15.0) 75.0 (16.0) 40-49 91.2 8.8 0.0 97.9 2.1 0.0 93.8 5.8 0.4 72.0 26.0 1.9 83.0 16.3 0.7 72.2 (15.4) 75.0 (20.0) 50-59 80.8 18.8 0.4 97.2 2.6 0.2 88.5 10.9 0.6 65.1 31.3 3.6 80.2 19.0 0.8 72.6 (17.5) 75.0 (30.0) 60-69 59.5 38.9 1.6 89.8 8.6 1.6 71.0 26.4 2.7 48.7 44.0 7.4 72.2 23.3 4.5 66.2 (19.8) 70.0 (30.0) 70-79 40.3 57.5 2.2 82.5 16.1 1.3 54.0 42.5 3.5 40.1 44.9 15.1 69.6 26.1 4.3 62.7 (22.4) 63.0 (30.0) 80-30.3 65.8 3.9 65.8 30.3 3.9 44.7 50.0 5.3 36.8 47.4 15.8 73.7 22.4 3.9 67.1 (26.1) 70.0 (40.0) Education Elementary or less 50.8 47.3 1.8 85.0 13.5 1.5 63.8 33.7 2.5 43.6 45.4 10.9 70.3 25.6 4.1 64.8 (21.6) 70.0 (30.0) Middle school 76.4 23.0 0.6 95.7 4.3 0.0 85.1 13.0 1.9 61.5 32.3 6.2 77.0 21.1 1.9 70.5 (17.2) 70.0 (20.0) High school 91.3 8.4 0.3 98.7 0.9 0.4 94.5 5.0 0.5 76.1 22.9 1.0 84.7 14.8 0.5 72.9 (15.7) 75.0 (20.0) University or more 96.3 3.7 0.0 99.3 0.7 0.0 95.9 4.0 0.1 78.9 20.4 0.7 88.6 11.2 0.1 74.6 (14.3) 80.0 (15.0) Occupation Non-manual 94.1 5.8 0.1 99.4 0.5 0.1 96.2 3.7 0.1 78.3 21.2 0.5 86.8 13.2 0.0 74.3 (14.5) 75.0 (16.0) Manual 77.8 21.8 0.4 95.8 4.0 0.1 86.8 13.2 0.0 64.5 32.2 3.3 84.0 14.3 1.7 71.3 (16.5) 70.0 (20.0) Others 69.5 29.3 1.2 90.6 8.4 1.1 76.2 21.5 2.4 57.8 34.6 7.6 74.8 22.5 2.6 68.0 (20.1) 70.0 (30.0) Subjective Very good 94.3 5.7 0.0 99.1 0.9 0.0 99.1 0.1 0.0 89.6 8.5 1.9 94.3 4.7 0.9 87.5 (10.8) 90.0 (15.0) health Good 90.3 9.5 0.2 97.9 1.7 0.4 95.1 4.4 0.5 80.2 18.4 1.4 90.9 8.6 0.5 79.7 (13.7) 80.0 (20.0) Moderate 84.9 14.9 0.2 97.5 2.1 0.4 91.4 8.3 0.4 71.6 27.0 1.4 83.4 16.1 0.5 70.3 (14.9) 70.0 (20.0) Bad 50.9 48.0 1.1 84.6 14.3 1.1 57.5 39.7 2.7 30.4 58.4 11.2 62.1 33.5 4.4 58.0 (19.0) 60.0 (20.0) Very bad 22.1 68.1 9.7 69.0 28.3 2.7 30.1 59.3 10.6 15.9 43.4 40.7 38.1 48.7 13.3 51.0 (21.8) 50.0 (40.0) Public Health Weekly Report, KCDC 543

Table 4. Difference between EQ-5D problem reporting and EQ VAS of KNHANES & -1 after socio-demographic factors adjustments Variables Mobility Self-care Usual activities Pain/discomfort Anxiety/depression EQ VAS OR p OR p OR p OR p OR p p Before 2005 1.00-1.00-1.00-1.00-1.00 - - - Adjusted 2007 2.10 0.01 2.17 0.01 1.76 0.01 1.16 0.01 1.04 0.41 0.78 0.08 Adjusted* 2005 1.00-1.00-1.00-1.00-1.00 - - - 2007 1.67 0.01 1.55 0.01 1.28 0.01 0.89 0.01 0.88 0.01 2.19 0.01 * Adjustments for socio-demographic factors such as sex, age, education, occupation, and residence Table 5. International comparison of EQ-5D problem rate and EQ VAS after age and sex standardization. Country Sample Mobility Self-care Usual Pain/ Anxiety/ EQ (investigation year) size activities discomfort depression VAS (N) (%) (%) (%) (%) (%) (score) Korea (2005) 24,700 10.3 2.5 8.6 29.8 17.8 72.7 Korea (2007) 2,981 15.0 3.8 10.8 29.5 17.5 71.7 Armenia (2002) 2,217 23.4 11.0 26.6 62.0 51.6 68.0 Belgium (2001) 1,274 11.8 2.8 13.9 41.2 20.4 81.5 Canada (1997) 1,517 14.0 2.0 12.4 35.9 28.3 80.8 Finland (1992) 2,411 17.6 4.1 15.5 37.5 13.9 80.5 Germany (1994, 1997, 1996) 824 16.1 2.6 11.8 35.4 17.7 83.0 Greece (1998) 464 13.1 5.8 9.8 16.1 10.3 78.7 Hungary (2000) 5,503 16.1 5.0 12.2 35.7 33.1 72.9 Japan (1998) 620 5.6 1.5 4.0 17.2 8.1 78.2 The Netherlands (1991) 851 3.6 2.5 14.0 29.5 16.8 81.9 The Netherlands (2001) 9,685 14.2 2.8 13.0 32.4 11.5 - New Zealand (1999) 1,327 15.0 3.2 17.0 34.9 19.9 81.5 Slovenia (2000) 742 28.7 13.1 31.8 46.1 35.7 76.7 Spain (1995, 1996,1999) 2,741 10.0 2.0 9.3 27.5 16.2 76.9 Sweden (1994, 1998) 3,603 8.3 1.5 7.0 40.9 29.0 83.7 UK (1993) 3,395 14.5 3.6 13.9 29.1 19.9 84.0 USA (2000) 13,646 14.2 0.2 12.8 36.3 28.3 80.5 Zimbabwe (2003) 2,350 18.6 6.3 17.3 39.8 38.8 76.9 544 Public Health Weekly Report, KCDC

Figure 1. Correlation between problem rate in each EQ-5D and EQ VAS and GNI per capita in 19 studies Public Health Weekly Report, KCDC 545

Serosurvey of human brucellosis, Q fever among livestock hygiene controllers, 2007 546 Public Health Weekly Report, KCDC

Table 1. Regional distribution of livestock hygiene controllers by region and gender Region Livestock hygiene controllers Male Female Total (%) Gyeonggi 33 1 34 (16.8) Gangwon 16 0 16 (7.9) Chungbuk 14 0 14 (6.9) Chungnam 27 0 27 (13.4) Jeonbuk 20 1 21 (10.4) Jeonnam 27 0 27 (13.4) Gyeongbuk 33 1 34 (16.8) Gyeongnam 26 0 26 (12.9) Jeju 3 0 3 (1.5) Total 199 3 202 (100.0) Public Health Weekly Report, KCDC 547

Table 2. Seroprevalence of brucellosis, Q fever among the livestock hygiene controllers No. of seropositivity Seroprevalence % Total Brucellosis 0 0.0 Q fever 4 2.0 198 548 Public Health Weekly Report, KCDC

Case reports of transfusion-transmitted malaria confirmed on epidemiological investigation Public Health Weekly Report, KCDC 549

Figure 1. The weekly proportion of influenza-like illness visits per 1,000 patients, 2007-2008 season - 2008-2009 season Figure 2. The number of influenza virus isolates, 2008-2009 season Figure 3. The weekly reported Malaria cases through National Notifiable Disease Surveillance System Figure 4. Cumulative reported Malaria cases through National Notifiable Disease Surveillance System All Causes 265* 14 6 39 110 96 P&I 17* 0 0 2 8 7 * Mortality data in this table are voluntarily reported from 40 hospitals, which of total discharged patients in 31 th week, 2009 are 15,756 All causes of death are defined from death certificates. Fetal deaths are not included. Pneumonia and influenza (KCD code J09-J18). 550 Public Health Weekly Report, KCDC

Cholera - - - 5 7 5 16 10 Plague - Typhoid fever 5 109 4 188 223 200 190 174 Paratyphoid fever 2 21 1 44 45 50 31 45 Shigellosis 1 60 5 209 131 389 317 487 Philippines(1) EHEC - 46 5 58 41 37 43 118 Diphtheria - Pertussis - 24-9 14 17 11 6 Tetanus - 10-16 8 10 11 11 Measles 1 23 1 2 194 28 7 11 Mumps 153 4,442 44 4,542 4,557 2,089 1,863 1,744 Rubella 3 26-30 35 18 12 15 Poliomyelitis - Japanese encephalitis - - - 6 7-6 - Varicella 362 19,976 212 22,849 20,284 11,027 1,934 - Malaria 46 619 87 1,052 2,227 2,051 1,369 864 Equatorial Guinea(1) Scarlet fever 1 98 1 151 146 108 87 80 Meningococcal meningitis - 3-1 4 11 7 8 Legionellosis 1 17-21 19 20 6 10 Malaysia(1) Vibrio vulnificus sepsis - 1 2 49 59 88 57 57 Epidemic typhus - Murine typhus - 6-87 61 73 35 19 Scrub typhus 6 142 1 6,057 6,022 6,480 6,780 4,698 Leptospirosis 2 10 1 100 208 119 83 141 Brucellosis 2 16 3 58 101 215 158 47 Anthrax - Rabies 1 HFRS - 90 2 375 450 422 421 427 Dengue fever - 34 2 51 97 35 34 16 Leishmaniasis 1 Babesiosis - - - - - - 1 - Cryptosporidiosis - - - - - - 1 - Botulism - - - - - 1-4 Q fever 1 14-19 12 6 - - Tuberculosis 850 23,474 657 34,157 34,710 35,361 35,269 31,503 HIV/AIDS 19 436 14 797 744 750 680 610 -: No reported cases. N : Not notifiable. Cum: Cumulative counts of the year from 1st week to current week. EHEC : Enterohemorrhagic Escherichia coli. HFRS : Hemorrhagic fever with renal syndrome. * Incidence data for reporting years 2009 are provisional, whereas data for 2004, 2005, 2006, 2007 and 2008 are finalized. * Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease respectively. Excluding Hansen's disease and diseases reported through the Laboratory Surveillance System and Sentinel Surveillance System(Data for Sentinel Surveillance System are available in Table III) and no case reported since 2003(Yellow fever, Marburg fever, Ebola fever, Lassa fever, African Trypanosomiasis, Schistosomiasis, Yaws, Pinta, Smallpox, Severe Acute Respiratory Syndrome, Avian influenza infection and humans, Tularemia, and Newly everging infectious disease syndrome) Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years.(in case of Varicella, used data for 3 years-2006,2007 and 2008, because of being designated as of July 13, 2005) HIV/AIDS is infected cases but not disease cases. Public Health Weekly Report, KCDC 551

Total - - 2 5 109 134 2 21 24 1 60 125-46 37-24 4-10 5 1 23 43 153 4,442 1,831 Seoul - - 2-17 22-3 6-9 9-6 3-5 1-1 1 1 4 22 16 719 222 Busan - - - - 13 14-2 2-8 18-1 - - - - - 1 - - 1 1 3 156 95 Daegu - - - 2 9 7 1 2 1-1 22-1 1 - - - - 2 - - 1 1 7 286 402 Incheon - - - - 2 4-1 1-5 7-1 2-3 - - - - - 1 6 55 1,074 185 Gwangju - - - - - 4-2 1-1 3-10 17-1 - - - - - 2 1 4 105 26 Daejeon - - - - - 6 - - - - 1 1-1 1-1 - - - - - 2-6 53 27 Ulsan - - - - 1 3 - - - - 1 3 - - - - 1 2 87 84 Gyeonggi - - - 1 20 24-6 5 1 12 20-7 4-7 3-1 1-8 5 45 1,355 429 Gangwon - - - 1 5 3 1 1 1-5 2 - - 1-1 - - - - - - 1 5 196 77 Chungbuk - - - - 2 5-1 1 - - 4-1 1 - - - - 2 - - - - 3 105 97 Chungnam - - - - 5 5-1 - - 3 4-1 - - 3 - - - - - - - 1 70 39 Jeonbuk - - - - 4 5-1 1-3 1-7 - - - - - 1 - - 3 1-26 21 Jeonnam - - - - 1 5 - - 1-2 13-6 1-1 - - - 1-1 - 3 54 18 Gyeongbuk - - - - 9 10 - - 2-3 7-1 2 - - - - 1 1 - - - - 100 62 Gyeongnam - - - 1 21 16 - - 2-5 9-3 2 - - - - 1 1 - - 1 1 42 32 Jeju - - - - - 1-1 - - 1 2 - - 2-2 - - - - - - 3 2 14 15 -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Incidence data for reporting years 2009 are provisional, whereas data for 2004, 2005, 2006, 2007 and 2008 are finalized. Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding years. Public Health Weekly Report, KCDC 552

Total 3 26 15 - - - 362 19,976 11,323 46 619 714 1 98 72-3 4 1 17 7-1 12-6 2 Seoul - 4 2 - - - 22 1,855 879 10 84 96-12 12-1 - - 7 4 - - 1-2 - Busan - 3 1 - - - 32 2,140 1,355 3 16 20-18 12 - - - - - - - - 1-1 - Daegu - 3 1 - - - 33 2,209 793 1 13 10-16 2 - - - - - Incheon - 1 2 - - - 29 1,439 938 6 69 130 1 3 15-1 1 1 1 - - - - - 2 - Gwangju - - - - - - 5 247 211 2 8 5-10 1 - - - - - Daejeon - - - - - - 22 597 202 2 12 7-6 - - - - - - Ulsan - - 1 - - - 25 992 642 1 10 7-2 3-1 - - 1 Gyeonggi 1 4 4 - - - 80 4,379 2,852 12 250 319-6 9 - - 2-3 2 - - 2-1 2 Gangwon - - - - - - 70 2,284 1,322 3 89 56-3 - - - - - 2 1 - - - - - - Chungbuk - - 1 - - - 4 637 281 3 9 9 - - 1 - - - - - Chungnam - - - - - - 6 371 75 2 13 10-5 - - - - - 1 Jeonbuk - 2 1 - - - 2 224 378-8 11-3 5 - - - - - - - - 1 - - - Jeonnam - 3 - - - - 12 532 307-5 8 - - 1 - - - - - - - - 4 - - - Gyeongbuk 1 3 1 - - - 14 921 452-17 12-10 4 - - - - - Gyeongnam 1 1 1 - - - - 474 290 1 16 13-4 7 - - 1-1 - - 1 3 - - - Jeju - 2 - - - - 6 675 346 - - 1 1 unknown - - - - - - --: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Incidence data for reporting years 2009 are provisional, whereas data for 2004, 2005, 2006, 2007 and 2008 are finalized. Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding years. (In case of Varicella, used data for 3 years - 2006, 2007 and 2008, because of being designated as of July 13, 2005) Public Health Weekly Report, KCDC 553

Total 6 142 60 2 10 13 2 16 69 - - - - 90 94-34 19 1 14 8 850 23,474 20,179 Seoul - 12 4 1 4 - - - 1 - - - - 8 11-9 6-2 - 242 6,108 5,632 Busan 1 7 5 - - - 3 1-3 1 - - - 81 2,186 2,040 Daegu - 2 1 - - 1-1 1 - - - - 2 1-3 2 - - 3 56 1,763 944 Incheon 1 9 1 - - 1 - - 1 - - - - 1 7-3 1-1 1 55 1,070 845 Gwangju - 2 2 - - - - 1 - - - - - 3 2 - - 1 - - - 7 710 535 Daejeon - 1 2 - - - 1 1 - - - 1 1-57 938 484 Ulsan - 2 - - - - 1 - - - - - - - 21 508 356 Gyeonggi - 22 10-1 3-2 5 - - - - 36 22-10 5-7 2 125 3,441 3,230 Gangwon - 7 4 - - 2-1 3 - - - - 10 8 - - - - 1-22 969 890 Chungbuk - 4 2-1 1 - - 7 - - - - 6 6 - - - - 2-10 525 473 Chungnam - 12 7-1 1-1 8 - - - - 4 8-1 1 - - 1 11 765 728 Jeonbuk 2 34 8-1 1 2 3 5 - - - - 5 9 - - 1 - - - 41 996 863 Jeonnam 1 10 6 - - 1-1 5 - - - - 2 5 - - - - - - 27 852 758 Gyeongbuk - 10 2 1 2 1-2 20 - - - - 8 9-1 1 - - - 47 999 917 Gyeongnam 1 9 5 - - 1-4 11 - - - - - 4-3 - - - 1 38 1,400 1,299 Jeju - 1 1 - - - - - - 1 - - - - 10 244 185 -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Incidence data for reporting years 2009 are provisional, whereas data for 2004, 2005, 2006, 2007 and 2008 are finalized. Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding years. Public Health Weekly Report, KCDC 554

3.3 32.6 11.4 1.8 9.4 7.1 1.5 4.9 4.5 1.8 9.0 16.6 4.4 19.0 24.6 1.8 13.4 12.4 -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Incidence data for reporting years 2008 and 2009 are provisional. Reported cases contains all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding years. Included stage I and II of Syphilis. Public Health Weekly Report, KCDC 555